A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

6.9K views

⸱

DOI:

10.3791/56605

⸱

December 8th, 2017

 ,  ,  , 

In This Article

Summary

Recombinant prototype foamy virus integrase protein is often contaminated with a bacterial nuclease during purification. This method identifies nuclease contamination and removes it from the final preparation of the enzyme.

Abstract

The integrase (IN) protein of the retrovirus prototype foamy virus (PFV) is a model enzyme for studying the mechanism of retroviral integration. Compared to IN from other retroviruses, PFV IN is more soluble and more amenable to experimental manipulation. Additionally, it is sensitive to clinically relevant human immunodeficiency virus (HIV-1) IN inhibitors, suggesting that the catalytic mechanism of PFV IN is similar to that of HIV-1 IN. IN catalyzes the covalent joining of viral complementary DNA (cDNA) to target DNA in a process called strand transfer. This strand transfer reaction introduces nicks to the target DNA. Analysis of integration reaction products can be confounded by the presence of nucleases that similarly nick DNA. A bacterial nuclease has been shown to co-purify with recombinant PFV IN expressed in Escherichia coli (E. coli). Here we describe a method to isolate PFV IN from the contaminating nuclease by heparin affinity chromatography. Fractions are easily screened for nuclease contamination with a supercoiled plasmid and agarose gel electrophoresis. PFV IN and the contaminating nuclease display alternative affinities for heparin sepharose allowing a nuclease-free preparation of recombinant PFV IN suitable for bulk biochemical or single molecule analysis of integration.

Introduction

Biochemical and single molecule studies of protein interactions with DNA require exceptionally pure recombinant proteins. Contaminating nucleases from bacteria can obscure the results of these assays. A contaminating nuclease has been found in preparations of recombinant proteins oxygen scavenger protocatechuate-3,4-dioxygenase (PCD) and prototype foamy virus (PFV) integrase (IN) isolated from Escherichia coli (E. coli)1,2,3.

Retroviral integration assays rely on the conversion of supercoiled DNA to nicked or linear products as a ....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Induce PFV IN Expression in E. coli

  1. Add 1 μL of PFV IN expression plasmid (10 ng/μL) to 20 μL of E. coli BL21(DE3) pLysS (20 μL aliquot of commercially available cells has >2 x 106 CFU/μg plasmid) in a 1.5 mL tube. Mix gently by finger tapping or flicking the tube. Incubate on ice 5 min.
    1. Heat shock for exactly 30 s in a 42 ˚C water bath and then immediately return to ice for 2 min.
    2. Add 80 μL of room temperature super optimal broth with catabolite repression (SOC) media. Incubate for 1 h at 37 ˚C with 225 revolutions per minut....

Access restricted. Please log in or start a trial to view this content.

Results

Recombinant PFV IN is often contaminated with a bacterial nuclease1. Biochemical integration assays depend on the quantitation of the conversion of supercoiled plasmid DNA to relaxed circles and linear products. The presence of a contaminating nuclease could lead to spurious quantitation of these assays. Expression of PFV IN with a hexahistidine tag is induced in E. coli (Figure 1) and first purified by nickel affinity chromatography (Fig.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Recombinant proteins that interact with DNA, such as DNA repair proteins, oxygen scavengers for single molecule microscopy applications, or retroviral integrases, should be free of contaminating bacterial nucleases2,3. These contaminants may confuse the interpretation of results during bulk biochemical or single molecule assays.

We have found that a bacterial nuclease frequently co-purifies with PFV IN. However, PFV IN displays an affi.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by NIH AI099854 and AI126742 to KEY.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BL21/DE3 Rosetta E. coliEMD Millipore70956-4
LB brothEMD biosciences1.10285.0500
AmpicillinAmresco0339
Chloramphenicol Amresco0230
PBSSigma-AldrichD8537
IPTG Denville ScientificCI8280
ZnCl2Sigma-Aldrich208086
Tris Ultra PureGojira Fine ChemicalsUTS1003
NaClP212121RP-S23020
PMSF Amresco0754
Imidazole Sigma-AldrichI0250
DTT P212121SV-DTT
UltraPure EDTAInvitrogen/Gibco15575
MgSO4Amresco0662
Agarose Denville ScientificCA3510
Ethidium bromideThermo Fisher ScientificBP1302
GlycerolFisher ScientificG37-20
Ni-NTA SuperflowQiagen30430
Heparin Sepharose 6 Fast FlowGE Healthcare Life Sciences17-0998-01
HRV14 3C protease EMD Chemicals71493-3

References

  1. Lopez, M. A. Jr, Mackler, R. M., Yoder, K. E. Removal of nuclease contamination during purification of recombinant prototype foamy virus integrase. J Virol Methods. 235, 134-138 (2016).
  2. Senavirathne, G., et al. Widespread nuclease....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Protein PurificationHeparin Affinity ChromatographyRecombinant ProteinSDS-PAGENuclease AssayAgarose Gel ElectrophoresisPlasmid DNAE. Coli Expression